This invention relates to MTP/Apo-B secretion inhibitors of Formula (I)
##STR00001## wherein R.sup.1--R.sup.7, X.sup.1, m and n are as defined
in the specification, as well as pharmaceutical compositions comprising
the compounds, and methods of use of the compounds and compositions. The
compounds of the invention are useful in treating obesity and associated
diseases, conditions or disorders.